US Stock MarketDetailed Quotes

PHAR Pharming Group

Watchlist
  • 10.000
  • +0.312+3.22%
Close May 10 16:00 ET
  • 9.540
  • -0.460-4.60%
Post 19:30 ET
673.44MMarket Cap-62500P/E (TTM)

Pharming Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Pharming Group Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 8, 2024

Revenue(YoY)

55.59M

+30.66%
EPS(YoY)

-0.19

0.00%
Analyst Rating

Buy

May 1, 2024

Pharming Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Oct 24, 20242024/Q3-- / 67.414M--
Aug 1, 20242024/Q2-- / 67.414M--
May 8, 20242024/Q151.723M / 65.541M--
Mar 14, 20242023/Q474.192M / ----
Oct 26, 20232023/Q363.005M / 56.330M--
Aug 3, 20232023/Q250.198M / 48.366M--
May 11, 20232023/Q138.755M / 44.710M--
Mar 16, 20232022/Q451.835M / 53.989M--
Oct 27, 20222022/Q353.875M / 53.628M--
Aug 4, 20222022/Q249.018M / 50.776M--
DatePeriodRevenue/EstimateEarnings Call
Oct 24, 20242024/Q3-- / 67.414M--
Aug 1, 20242024/Q2-- / 67.414M--
May 8, 20242024/Q151.723M / 65.541M--
Mar 14, 20242023/Q474.192M / ----
Oct 26, 20232023/Q363.005M / 56.330M--
Aug 3, 20232023/Q250.198M / 48.366M--
May 11, 20232023/Q138.755M / 44.710M--
Mar 16, 20232022/Q451.835M / 53.989M--
Oct 27, 20222022/Q353.875M / 53.628M--
Aug 4, 20222022/Q249.018M / 50.776M--

Unlock Free Earnings Estimates

Pharming Group Earnings Reports

  • Pharming Group | 6-K: Report of foreign private issuer (related to financial reporting)

    May 8 06:08 ET

  • Pharming Group | 20-F: Registration statement / Annual report / Transition report

    Apr 4 08:10 ET

  • Pharming Group | 6-K: Report of foreign private issuer (related to financial reporting)

    Mar 14 06:38 ET

  • Pharming Group | 6-K: Report of foreign private issuer (related to financial reporting)

    Jan 8 00:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 1, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg